SMITHKLINE BEECHAM RESEARCH LIMITED

SMITHKLINE BEECHAM RESEARCH LIMITED in the Philippines is neither a factory nor a trading company. It is a research and development institution.

Company Introduction:

SMITHKLINE BEECHAM RESEARCH LIMITED

Location: Philippines

SmithKline Beecham Research Limited was a dedicated research and development (R&D) facility that operated as part of the global pharmaceutical giant, SmithKline Beecham. Its primary function was scientific research, drug discovery, and development within the pharmaceutical and healthcare sectors.

Key Characteristics:

Nature of Business: Research and Development (R&D). This entity focused on scientific investigation, preclinical research, drug candidate identification, and potentially early-stage clinical development, rather than large-scale manufacturing or commercial trading of finished products.

Industry: Pharmaceutical, Biotechnology, Healthcare.

Activities: Its operations would have encompassed various aspects of pharmaceutical R&D, including medicinal chemistry, pharmacology, toxicology, drug metabolism, and potentially formulation science, aimed at discovering and developing new medicines and vaccines.

Historical Context: SmithKline Beecham was a major multinational pharmaceutical company that later merged with Glaxo Wellcome in 2000 to form GlaxoSmithKline (GSK). Entities like SmithKline Beecham Research Limited were crucial components of the parent company's innovation pipeline, responsible for generating the intellectual property and scientific data that underpin new pharmaceutical products. While directly contributing to the product pipeline, it did not engage in the mass production of drugs (factory) or the buying and selling of goods (trading).

SMITHKLINE BEECHAM RESEARCH LIMITED was primarily a research and development entity and did not directly produce or sell finished pharmaceutical or consumer healthcare products in the Philippines or elsewhere. Its focus was on scientific discovery and drug development.

However, the parent company, SmithKline Beecham (which later merged to form GlaxoSmithKline or GSK), had commercial operations that sold a wide range of products in the Philippines. These products, many of which originated from the research efforts of entities like SMITHKLINE BEECHAM RESEARCH LIMITED, included:

Pharmaceuticals:

Amoxil (amoxicillin)

Augmentin (amoxicillin/clavulanate)

Seroxat / Paxil (paroxetine)

Tagamet (cimetidine)

Consumer Healthcare Products:

Tums (antacid)

Aquafresh (toothpaste)

Horlicks (malted milk drink)

These products were sold through SmithKline Beecham's commercial presence in the Philippines.